Search Within

Glenn Heller

Formats
  1. Journal Article (268)
  2. Meeting Abstract (123)
  3. Conference Paper (9)
Groups
  1. Biostatistics Service (400)
  2. Epidemiology and Biostatistics (400)
  3. Department of Medicine (300)
  4. GSK Faculty (193)
  5. Center for Hematologic Malignancies (162)
  6. Pediatrics, Department of (158)

More Groups

People
  1. Howard Scher (89)
  2. Richard O'Reilly (75)
  3. Nancy Kernan (59)
  4. Michael Morris (54)
  5. James Young (52)
  6. Marcel Van Den Brink (47)

More People

Years
  1. 2025 (4)
  2. 2024 (6)
  3. 2023 (9)
  4. 2022 (9)
  5. 2021 (9)
  6. 2020 (12)

More Years

Publications
  1. Journal of Clinical Oncology (82)
  2. Blood (69)
  3. Biology of Blood and Marrow Transplantation (32)
  4. Clinical Cancer Research (24)
  5. Bone Marrow Transplantation (13)
  6. Cancer (13)

More Publications

Publishers
  1. American Society of Clinical Oncology (84)
  2. American Society of Hematology (70)
  3. Elsevier Inc. (41)
  4. American Association for Cancer Research (40)
  5. Nature Publishing Group (26)
  6. Elsevier Science, Inc. (24)

More Publishers

Results (400)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Influence of infused cell dose and HLA match on engraftment after double-unit cord blood allografts
    Journal Article

    Avery, S.; Shi, W.; Lubin, M.; Gonzales, A. M.; Heller, G.; Castro-Malaspina, H.; Giralt, S.; Kernan, N. A.; Scaradavou, A.; Barker, J. N.
    Blood (2011)

    Fulltext@MSK | Save
  • Docetaxel (D) plus high-dose calcitriol versus D plus prednisone (P) for patients (Pts) with progressive castration-resistant prostate cancer (CRPC): Results from the phase III ASCENT2 trial
    Meeting Abstract

    Scher, H. I.; Chi, K. N.; De Wit, R.; Berry, W. R.; Albers, P.; Henick, B.; Venner, P.; Heidenreich, A.; Chu, L.; Heller, G.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Fluorodeoxyglycose (FDG) PET as an outcome measure for metastatic prostate cancer
    Meeting Abstract

    Morris, M. J.; Fox, J. J.; Dennis, E. R.; Tse, K.; Flatts, E.; Heller, G.; Jia, X.; Schoder, H.; Larson, S. M.; Scher, H. I.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Circulating tumor cells (CTC) and prostate specific antigen (PSA) as response indicator biomarkers in chemotherapy-naive patients with progressive castration-resistant prostate cancer (CRPC) treated with MDV3100
    Meeting Abstract

    Anand, A.; Scher, H. I.; Beer, T. M.; Higano, C. E.; Danila, D. C.; Taplin, M.; Efstathiou, E.; Hirmand, M.; Sawyers, C. L.; Heller, G.; more...
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • A novel reduced intensity conditioning can induce a high incidence of sustained donor engraftment after double unit cord blood transplantation (CBT) without anti-thymocyte globulin
    Meeting Abstract

    Ponce, D. M.; Sauter, C.; Lubin, M.; Gonzales, A. M.; Heller, G.; Castro-Malaspina, H.; Giralt, S.; Kernan, N. A.; Papadopoulos, E. B.; Scaradavou, A.; more...
    Blood (2010)

    Fulltext@MSK | Save
  • Recombinant human interleukin-7 (CYT107) enhances CD4 and CD8 T cell recovery following T-Cell depleted allogeneic hematopoietic stem cell transplant in patients with myeloid malignancies
    Meeting Abstract

    Perales, M. A.; Goldberg, J. D.; Lechner, L.; Yuan, J.; Papadopoulos, E.; Young, J. W.; Jakubowski, A. A.; Koehne, G.; Gallardo, H.; Kendle, R.; more...
    Blood (2010)

    Fulltext@MSK | Save
  • Abrogation of donor T cell IL-21 signaling leads to tissue-specific modulation of immunity and separation of GVHD From GVL
    Meeting Abstract

    Hanash, A. M.; Kappel, L. W.; Yim, N. L.; Nejat, R. A.; Goldberg, G. L.; Smith, O. M.; Rao, U. K.; Dykstra, L.; Na, I. K.; Holland, A. M.; more...
    Blood (2010)

    Fulltext@MSK | Save
  • Analytical strategies for characterizing chemotherapy diffusion with patient-level population-based data
    Journal Article

    Sima, C. S.; Panageas, K. S.; Heller, G.; Schrag, D.
    Applied Health Economics and Health Policy (2010)

    Fulltext@MSK | Save
  • Second-line age-adjusted International Prognostic Index in patients with advanced non-Hodgkin lymphoma after T-cell depleted allogeneic hematopoietic SCT
    Journal Article

    Perales, M. A.; Jenq, R.; Goldberg, J. D.; Wilton, A. S.; Lee, S. S. E.; Castro-Malaspina, H. R.; Hsu, K.; Papadopoulos, E. B.; van den Brink, M. R. M.; Boulad, F.; more...
    Bone Marrow Transplantation (2010)

    Fulltext@MSK | Save
  • Inhibition of neovascularization to simultaneously ameliorate graft-vs-host disease and decrease tumor growth
    Journal Article

    Penack, O.; Henke, E.; Suh, D.; King, C. G.; Smith, O. M.; Na, I. K.; Holland, A. M.; Ghosh, A.; Lu, S. X.; Jenq, R. R.; more...
    JNCI: Journal of the National Cancer Institute (2010)

    Fulltext@MSK | Save